It is estimated that over 1.9 million people in the United States suffer from substance use disorders related to prescription opioid pain relievers.
TriggerLock™ is a proprietary and innovative drug delivery platform with the potential to provide a controlled release of opioid analge sics while deterring abuse.
- Trigger Lock Technology™ has the potential to provide:
- Sustained release Micropump®- based particles that are resistant to crushing
- Resistance of drug extraction through alcohol, water and other mediums
- Prevention of abuse by injection through use of viscosifying ingredients
- Preservation of the drug's bioavailability
Avadel is actively seeking partnership opportunities for Trigger Lock™.
Please contact our business development team for more information.